You are viewing the site in preview mode

Skip to main content

Advertisement

Figure 9 | BMC Infectious Diseases

Figure 9

From: Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice

Figure 9

Survival rate of mice immunized with CAV-2-ROP18 (), CAV-2 (Δ), PBS (☼) and nothing (*), then challenged with 1 × 103tachyzoites. Each group had 20 mice. Statistically significant differences (P < 0.05) are indicated by an asterisk (*), which of CAV-2-ROP18 are listed differently compared to the other other control groups.

Back to article page